| Detected | Trial | Change |
|---|---|---|
| 2026-07-21 | NCT05889182 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… |
date change Completion pushed: 2028-03 -> 2028-09 |
| 2026-07-21 | NCT06772623 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… |
Trial sites expanded: 107 -> 110 locations |
| 2026-07-21 | NCT07567781 A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-21 | NCT07413133 A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to… |
Trial completed |
| 2026-07-21 | NCT07600762 A Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib… |
overall status: "Not Yet Recruiting" → "Completed" |
| 2026-07-19 | NCT06806293 Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult… |
Primary endpoint(s) modified |
| 2026-07-19 | NCT06806293 Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult… |
date change Primary completion moved earlier: 2027-02 -> 2026-08 |
| 2026-07-19 | NCT06417775 Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-19 | NCT07155174 A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of… |
date change Primary completion moved earlier: 2029-05 -> 2029-04 |
| 2026-07-17 | NCT05496348 Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-17 | NCT04928846 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… |
Enrollment increased: 698 -> 768 participants |
| 2026-07-17 | NCT04928846 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… |
date change Primary completion pushed: 2028-03 -> 2028-12 |
| 2026-07-17 | NCT04928846 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… |
date change Completion pushed: 2028-03 -> 2029-02 |
| 2026-07-14 | NCT07587008 Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-07-11 | NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis |
Trial sites expanded: 101 -> 104 locations |
| 2026-07-10 | NCT07155187 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV)… |
Primary endpoint(s) modified |
| 2026-07-10 | NCT07155187 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV)… |
Enrollment increased: 430 -> 490 participants |
| 2026-07-10 | NCT07155187 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV)… |
Trial arms changed: 4 -> 6 |
| 2026-07-10 | NCT07155187 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV)… |
Trial sites expanded: 53 -> 110 locations |
| 2026-07-10 | NCT07525206 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV… |
Trial sites expanded: 10 -> 13 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-13 | NCT07697456 Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to… | Phase 2 | Not Yet Recruiting |
| 2026-07-08 | NCT07690215 Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of… | Not Yet Recruiting | |
| 2026-07-07 | NCT07687602 A Study to Evaluate Adverse Events and Change in Disease Activity of Mirvetuximab… | Not Yet Recruiting | |
| 2026-07-02 | NCT07680686 Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in… | Phase 1 | Not Yet Recruiting |
| 2026-06-29 | NCT07673107 Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult… | Phase 2 | Recruiting |
| 2026-06-29 | NCT07673120 A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07044687 | Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in… | Acute Myeloid Leukemia | Recruiting |
| NCT07186595 | A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult… | Mid Face Volume Deficit | Active, Not Recruiting |
| NCT05821855 | A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma… | Open-angle Glaucoma | Active, Not Recruiting |
| Phase 3 | |||
| NCT06461897 | A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral… | Atopic Dermatitis | Recruiting |
| NCT06428019 | A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT05407636 | Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD | AMD | Recruiting |
| NCT05609630 | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT05995353 | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and… | Crohn's Disease | Recruiting |
| NCT05125302 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… | Migraine | Recruiting |
| NCT06734351 | A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult… | Mid Face Volume Deficit | Recruiting |
| NCT06332534 | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric… | Crohn's Disease | Recruiting |
| NCT04777357 | A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in… | Depression | Recruiting |
| NCT06100744 | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT06389136 | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis… | Atopic Dermatitis | Recruiting |
| NCT06158841 | Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… | Multiple Myeloma | Recruiting |
| NCT07007065 | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT06012240 | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and… | Alopecia Areata | Recruiting |
| NCT05711394 | A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant… | Episodic Migraine | Recruiting |
| NCT06575192 | Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast… | Breast Reconstruction | Recruiting |
| NCT06810505 | A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity… | Chronic Migraine | Recruiting |
| NCT04928846 | A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab… | Non Small Cell Lung Cancer | Recruiting |
| NCT07071519 | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… | Ulcerative Colitis | Recruiting |
| NCT05889182 | A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… | Hidradenitis Suppurativa | Recruiting |
| NCT06822738 | A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation… | Primary Open Angle Glaucoma | Recruiting |
| NCT07525206 | A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV… | Colorectal Cancer | Recruiting |